2019/06/28 08:01:05 | |
---|---|
Price | |
80.10 EUR | |
Difference | -0.22% (-0.18) |
ISIN | CH0012005267 |
Symbol | NOVN |
Exchange | Hanover |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 177,766 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 80.10 EUR |
High | 80.10 EUR |
Low | 80.10 EUR |
Close (prev. day) | 80.28 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 30 |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2019/06/28 08:01:05 | |
---|---|
Price | |
80.10 EUR | |
Difference | -0.22% (-0.18) |
ISIN | CH0012005267 |
Symbol | NOVN |
Exchange | Hanover |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 177,766 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 80.10 EUR |
High | 80.10 EUR |
Low | 80.10 EUR |
Close (prev. day) | 80.28 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +23.68% | +44.79% | +28.75% |
Perf (abs.) | +15.34 | +24.78 | +17.88 |
Beta | 0.77 | 0.86 | 0.78 |
Volatility | 20.37 | 19.22 | 18.67 |
Ø price 5 days | Ø volume 5 days (pcs.) | 80.84 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 78.31 EUR (42) |
Ø price 100 days | Ø volume 100 days (pcs.) | 73.64 EUR (52) |
Ø price 250 days | Ø volume 250 days (pcs.) | 68.55 EUR (69) |
YTD High | date | 81.96 EUR (2019/06/21) |
YTD Low | date | 64.76 EUR (2019/01/03) |
52 Weeks High | date | 81.96 EUR (2019/06/21) |
52 Weeks Low | date | 56.59 EUR (2018/07/03) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Stuttgart | 2019/06/28 | 21:58 | 80.10 EUR | 0.04 | 11 |
SIX Swiss Exchange | 2024/03/28 | 17:30 | 87.37 CHF | 257.33 | 11,258 |
London Stock Exchange European Trade Reporting | 2024/03/28 | 17:20 | 86.725 CHF | 5.63 | 29 |
Hanover | 2019/06/28 | 08:01 | 80.10 EUR | 0.00 | 2 |
Hamburg | 2019/06/28 | 14:05 | 80.19 EUR | 0.08 | 4 |
Frankfurt | 2019/06/28 | 19:57 | 80.16 EUR | 0.13 | 13 |
FINRA other OTC Issues | 2024/03/28 | 18:58 | 96.51 USD | 0.03 | 3 |
Duesseldorf | 2019/06/28 | 14:08 | 80.18 EUR | 0.00 | 2 |
Berlin | 2019/06/28 | 18:45 | 80.40 EUR | 0.00 | 16 |
BX Swiss | 2024/03/28 | 18:00 | 87.294 CHF | 0.08 | 10 |
NOVARTIS AG |
- - |
Lichtstrasse 35 - 4056 Basel |
Telefon: +41-61-324-11-11 |
Fax: + |
E-mail: - |
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland. |
Vasant Narasimhan, M.D. | Chairman of Managing Board |
James E. Bradner | Member of Executive Committee |
Klaus Moosmayer | Member of Executive Committee |
Steffen Lang | Member of Executive Committee |
Susanne Schaffert | Member of Executive Committee |
Harry Kirsch | Member of Executive Committee |
John Tsai, M.D. | Member of Executive Committee |
Karen L. Hale | Member of Executive Committee |
Marie-France Tschudin | Member of Executive Committee |
Richard Saynor | Member of Executive Committee |
Rob Kowalski | Member of Executive Committee |
Robert Weltevreden | Member of Executive Committee |
Charles Sawyers | Member of the administrative board |
Nancy Andrews | Member of the administrative board |
Simon Moroney | Member of the administrative board |
Ana de Pro Gonzalo | Member of the administrative board |
Bridgette Heller | Member of the administrative board |
Daniel Hochstrasser | Member of the administrative board |
Frans van Houten | Member of the administrative board |
John Young | Member of the administrative board |
Mary Doherty | Member of the administrative board |
Patrice Bula | Member of the administrative board |
Ton Büchner | Member of the administrative board |
William Winters | Member of the administrative board |
Hans Jörg Reinhardt | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer